Hepatotoxicity of copper sulfide nanoparticles towards hepatocyte spheroids using a novel multi-concave agarose chip method

Nanomedicine (Lond). 2021 Jul;16(17):1487-1504. doi: 10.2217/nnm-2021-0011. Epub 2021 Jun 29.

Abstract

Aim: To explore the hepatotoxicity of copper sulfide nanoparticles (CuSNPs) toward hepatocyte spheroids. Materials & methods: Other than the traditional agarose method to generate hepatocyte spheroids, we developed a multi-concave agarose chip (MCAC) method to investigate changes in hepatocyte viability, morphology, mitochondrial membrane potential, reactive oxygen species and hepatobiliary transporter by CuSNPs. Results: The MCAC method allowed a large number of spheroids to be obtained per sample. CuSNPs showed hepatotoxicity in vitro through a decrease in spheroid viability, albumin/urea production and glycogen deposition. CuSNPs also introduced hepatocyte spheroid injury through alteration of mitochondrial membrane potential and reactive oxygen species, that could be reversed by N-acetyl-l-cysteine. CuSNPs significantly decreased the activity of BSEP transporter by downregulating its mRNA and protein levels. Activity of the MRP2 transporter remained unchanged. Conclusion: We observed the hepatotoxicity of CuSNPs in vitro with associated mechanisms in an advanced 3D culture system.

Keywords: copper sulfide nanoparticles; hepatobiliary transporters; hepatotoxicity; reactive oxygen species; spheroids.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Chemical and Drug Induced Liver Injury*
  • Copper / toxicity
  • Hepatocytes
  • Humans
  • Nanoparticles* / toxicity
  • Sepharose
  • Spheroids, Cellular
  • Sulfides / toxicity

Substances

  • Sulfides
  • Copper
  • Sepharose